|
시장보고서
상품코드
2054153
폐용 약물전달 시스템 시장 규모, 점유율, 성장 분석 : 제품 유형별, 용도별, 약물 유형별, 유통 채널별, 최종사용자별, 기술별, 지역별 - 업계 예측(2026-2033년)Pulmonary Drug Delivery Systems Market Size, Share, and Growth Analysis, By Product Type, By Application, By Drug Type, By Distribution Channel, By End User, By Technology, By Region - Industry Forecast 2026-2033 |
||||||
세계의 폐용 약물전달 시스템 시장 규모는 2024년에 565억 달러로 평가되었으며, 2025년 591억 달러에서 2033년까지 846억 9,000만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 4.6%로 성장할 것으로 전망됩니다.
세계 폐용 약물전달 시스템 시장은 표적화된 흡입 요법을 필요로 하는 호흡기질환의 유병률 증가로 인해 크게 견인되고 있습니다. 이 시장에는 정량 분무식 흡입기, 건조 분말 흡입기, 분무기, 소프트 미스트 흡입기 등 다양한 장치와 제제가 포함됩니다. 폐로의 전달은 빠른 작용 발현, 높은 국소 농도, 낮은 전신 독성 등의 장점을 가지고 있어 흡입 요법의 기술적 진보를 위한 길을 열어주었습니다. 스마트 흡입기 기술이 복약 순응도 데이터를 제공하고 환자 치료를 개선함에 따라, 임상 결과와 기기 보급을 촉진하는 혁신의 중요성이 점점 더 커지고 있습니다. 또한, 흡입용 바이오의약품 및 백신 제제 기술의 발전으로 제약회사들은 전신 투여에 대한 적용을 모색할 수 있게 되었고, 그 결과 새로운 수익 기회와 파트너십을 창출하여 시장 성장을 더욱 촉진하고 치료 용도를 확장하고 있습니다.
세계 폐용 약물전달 시스템 시장의 성장요인
세계 폐용 약물전달 시스템 시장의 주요 시장 촉진요인은 천식, 만성폐쇄성폐질환(COPD)과 같은 호흡기질환의 유병률 증가로 인해 효과적이고 효율적인 치료법이 요구되고 있습니다. 전 세계적으로 고령화와 환경오염물질에 대한 노출이 증가함에 따라 전신 부작용을 최소화하고 치료 효과를 극대화하는 표적형 약물전달 시스템에 대한 수요가 지속적으로 증가하고 있습니다. 또한, 휴대성과 사용 편의성이 개선된 분무기 및 흡입기 개발 등 기술 발전은 환자의 복약 순응도를 높이고 호흡기질환에 대한 적시 개입을 가능하게함으로써 시장 성장을 더욱 촉진하고 있습니다.
세계 폐용 약물전달 시스템 시장의 억제요인
세계 폐용 약물전달 시스템 시장의 주요 시장 억제요인 중 하나는 이러한 의료기기와 관련된 규제 당국의 강화된 감시와 엄격한 승인 프로세스입니다. 규제 당국은 안전성, 유효성 및 제조 관행에 대해 엄격한 기준을 적용하고 있으며, 이는 제조업체의 개발 기간 연장 및 비용 증가로 이어질 수 있습니다. 또한, 기존 투약 방식과 비교하여 폐용 장치의 성능을 평가하는 복잡성은 투자와 혁신을 저해하는 요인이 될 수 있습니다. 이러한 복잡한 규제 환경은 신규 진입자의 시장 진입을 제한하고, 폐용 약물전달 시스템 부문 전체의 성장 잠재력을 저해할 수 있습니다.
세계 폐용 약물전달 시스템 시장 동향
세계 폐용 약물전달 시스템 시장은 디지털 통합의 발전, 특히 커넥티드 흡입기 생태계와 센서 장착 장치를 통해 큰 변화를 겪고 있습니다. 이를 통해 지속적인 모니터링, 원격 투약량 조절, 그리고 환자 치료에 있어 매우 중요한 실제 생활에서의 복약 순응도에 대한 심층적인 인사이트를 얻을 수 있습니다. 원격의료 플랫폼과의 통합과 데이터 분석의 활용으로 개인화된 케어 경로와 가치에 기반한 계약이 확산되고 있습니다. 또한, 의료기기 제조업체는 소프트웨어 회사와 전략적 제휴를 맺어 종합적인 솔루션을 제공함으로써 애프터마켓 서비스와 지속적인 수익원을 창출할 수 있는 길을 열어주고 있습니다. 이러한 추세는 전통적인 판매 모델을 넘어 환자 참여, 상호운용성, 증거에 기반한 성과에 중점을 두고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 폐용 약물전달 시스템 시장 규모 : 제품 유형별
세계의 폐용 약물전달 시스템 시장 규모 : 용도별
세계의 폐용 약물전달 시스템 시장 규모 : 약물 유형별
세계의 폐용 약물전달 시스템 시장 규모 : 유통 채널별
세계의 폐용 약물전달 시스템 시장 규모 : 최종사용자별
세계의 폐용 약물전달 시스템 시장 규모 : 기술별
세계의 폐용 약물전달 시스템 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.06.12Global Pulmonary Drug Delivery Systems Market size was valued at USD 56.5 Billion in 2024 and is poised to grow from USD 59.1 Billion in 2025 to USD 84.69 Billion by 2033, growing at a CAGR of 4.6% during the forecast period (2026-2033).
The global pulmonary drug delivery systems market is significantly driven by the increasing prevalence of respiratory diseases necessitating targeted inhalation therapies. This market encompasses a variety of devices and formulations, including metered-dose inhalers, dry powder inhalers, nebulizers, and soft-mist inhalers. Pulmonary delivery offers advantages such as rapid onset, higher local concentrations, and reduced systemic toxicity, paving the way for technological advancements in inhalation therapies. Innovations enhancing clinical outcomes and device adoption are increasingly pivotal, as smart inhaler technologies provide adherence data and improve patient care. Furthermore, advancements in formulations for inhaled biologics and vaccines enable pharmaceutical companies to explore systemic applications, thus creating new revenue opportunities and partnerships that further drive market growth and expand therapeutic uses.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pulmonary Drug Delivery Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pulmonary Drug Delivery Systems Market Segments Analysis
Global pulmonary drug delivery systems market is segmented by product type, application, drug type, distribution channel, end user, technology and region. Based on product type, the market is segmented into Inhalers, Nebulizers, Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers and Others. Based on application, the market is segmented into Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Pulmonary Arterial Hypertension, Respiratory Infections and Others. Based on drug type, the market is segmented into Bronchodilators, Corticosteroids, Combination Drugs, Antibiotics, Biologics and Others. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on end user, the market is segmented into Hospitals, Clinics, Homecare Settings and Ambulatory Care Centers. Based on technology, the market is segmented into Conventional Delivery Systems, Smart Inhalation Systems and Breath-Actuated Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pulmonary Drug Delivery Systems Market
A key market driver for the Global Pulmonary Drug Delivery Systems Market is the increasing prevalence of respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), which necessitate effective and efficient treatment options. As the global population ages and exposure to environmental pollutants rises, the demand for targeted drug delivery systems that minimize systemic side effects and maximize therapeutic efficacy continues to grow. Additionally, advancements in technology, including the development of nebulizers and inhalers with enhanced portability and usability, are further propelling market growth by improving patient compliance and enabling timely intervention in respiratory conditions.
Restraints in the Global Pulmonary Drug Delivery Systems Market
One significant market restraint for the global pulmonary drug delivery systems market is the increasing regulatory scrutiny and stringent approval processes associated with these medical devices. Regulatory bodies impose rigorous standards for safety, efficacy, and manufacturing practices, which can lead to longer development times and higher costs for manufacturers. Additionally, the complexity of evaluating the performance of pulmonary devices against traditional delivery methods can deter investment and innovation. This intricate regulatory landscape may limit market entry for new players and hinder the overall growth potential of the pulmonary drug delivery systems sector.
Market Trends of the Global Pulmonary Drug Delivery Systems Market
The Global Pulmonary Drug Delivery Systems market is undergoing a significant evolution driven by advancements in digital integration, particularly through connected inhaler ecosystems and sensor-enabled devices. This transformation allows for continuous monitoring, remote titration, and enhanced insights into real-world adherence, which are pivotal for patient care. By integrating with telehealth platforms and leveraging data analytics, personalized care pathways and value-based contracting are gaining traction. Additionally, device manufacturers are forming strategic partnerships with software firms to offer comprehensive solutions, paving the way for aftermarket services and recurring revenue streams. This trend emphasizes patient engagement, interoperability, and evidence-based outcomes, moving beyond traditional sales models.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
- Value Chain Analysis
- Case Studies
- Technology Assessment
- Customer & Buying Criteria Analysis
- Pipeline Analysis
- Disease Epidemiology
Global Pulmonary Drug Delivery Systems Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Inhalers
- Nebulizers
- Dry Powder Inhalers (DPIs)
- Metered Dose Inhalers (MDIs)
- Soft Mist Inhalers
- Others
Global Pulmonary Drug Delivery Systems Market Size by Application & CAGR (2026-2033)
- Market Overview
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Cystic Fibrosis
- Pulmonary Arterial Hypertension
- Respiratory Infections
- Others
Global Pulmonary Drug Delivery Systems Market Size by Drug Type & CAGR (2026-2033)
- Market Overview
- Bronchodilators
- Corticosteroids
- Combination Drugs
- Antibiotics
- Biologics
- Others
Global Pulmonary Drug Delivery Systems Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Pulmonary Drug Delivery Systems Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Clinics
- Homecare Settings
- Ambulatory Care Centers
Global Pulmonary Drug Delivery Systems Market Size by Technology & CAGR (2026-2033)
- Market Overview
- Conventional Delivery Systems
- Smart Inhalation Systems
- Breath-Actuated Systems
Global Pulmonary Drug Delivery Systems Market Size & CAGR (2026-2033)
- North America (Product Type, Application, Drug Type, Distribution Channel, End User, Technology)
- US
- Canada
- Europe (Product Type, Application, Drug Type, Distribution Channel, End User, Technology)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Application, Drug Type, Distribution Channel, End User, Technology)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Application, Drug Type, Distribution Channel, End User, Technology)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Application, Drug Type, Distribution Channel, End User, Technology)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- GlaxoSmithKline
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vectura Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Chiesi Farmaceutici
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cipla
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- 3M
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hovione
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Recipharm
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Berry Global
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kindeva Drug Delivery
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PARI Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AptarGroup
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Catalent
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MannKind Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Phillips-Medisize
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nemera
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gerresheimer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
